ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.39085C>A (p.Pro13029Thr)

gnomAD frequency: 0.00002  dbSNP: rs397517553
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000040188 SCV000063879 likely benign not specified 2015-03-11 criteria provided, single submitter clinical testing p.Pro10595Thr in exon 156 of TTN: This variant is not expected to have clinical significance because it has been identified in 0.6% (101/16512) of South Asian c hromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs397517553).
Eurofins Ntd Llc (ga) RCV000040188 SCV000226382 likely benign not specified 2014-12-23 criteria provided, single submitter clinical testing
GeneDx RCV000040188 SCV000236756 benign not specified 2018-01-08 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000465574 SCV000555570 benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-27 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001170386 SCV001332963 benign Cardiomyopathy 2017-12-08 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839597 SCV002101244 benign Autosomal recessive limb-girdle muscular dystrophy type 2J 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839598 SCV002101245 benign Myopathy, myofibrillar, 9, with early respiratory failure 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839599 SCV002101246 benign Early-onset myopathy with fatal cardiomyopathy 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839596 SCV002101248 benign Tibial muscular dystrophy 2021-09-10 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002504909 SCV002800356 benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 2021-08-13 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV003137564 SCV003823616 uncertain significance not provided 2023-09-22 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV003137564 SCV005075227 likely benign not provided 2024-08-01 criteria provided, single submitter clinical testing TTN: BP4
PreventionGenetics, part of Exact Sciences RCV004541150 SCV004764028 likely benign TTN-related disorder 2023-04-25 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.